tanimilast

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug Nametanimilast
Drug Alias NameCHF 6001 NEXThaler®CHF 6001 NEXThaler DPICHF 6001 NEXThalerCHF-6001CH-6001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaBronchitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[37] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPA
Inactive CompaniesBeijing Kendlewits Medical Consulting Co Ltd
Active IndicationsAsthma
Inactive IndicationsPulmonary Disease, Chronic ObstructiveBronchitis, Chronic

Other Information

ATC CodeN/A
Related LinksN/A